Viktor Farkas

Dr. Viktor Farkas

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2014 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
BKBianka Kótai
Bianka Kótai
GKGyörgy Kardos
György Kardos
AHAndrea Hamza
Andrea Hamza
VFViktor Farkas
Viktor Farkas
IPImre Pápai
Imre Pápai
TSTibor Soós
Tibor Soós

28 December 2007 in Biochemistry
Verified
Journal Article
Closed access
PHPéter Hudáky
Péter Hudáky
PSPál Stráner
Pál Stráner
VFViktor Farkas
Viktor Farkas
GVGyörgyi Váradi
Györgyi Váradi
GTGábor Tóth
Gábor Tóth
APAndrás Perczel
András Perczel

6 June 2011 in Journal of Peptide Science
Verified
Journal Article
Closed access
PDF file
PRPetra Rovó
Petra Rovó
VFViktor Farkas
Viktor Farkas
OHOrsolya Hegyi
Orsolya Hegyi
OSOrsolya Szolomájer‐Csikós
Orsolya Szolomájer‐Csikós
GTGábor K. Tóth
Gábor K. Tóth
APAndras Perczel
Andras Perczel

12 January 2021 in Organic Process Research & Development
Verified
Journal Article
Closed access
VFViktor Farkas
Viktor Farkas
KFKristóf Ferentzi
Kristóf Ferentzi
KHKata Horváti
Kata Horváti
APAndras Perczel
Andras Perczel

26 March 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
LKLászló Keresztes
László Keresztes
ESEvelin Szögi
Evelin Szögi
BVBálint Varga
Bálint Varga
VFViktor Farkas
Viktor Farkas
APAndras Perczel
Andras Perczel
Vince GrolmuszVince Grolmusz
Vince Grolmusz
The amyloid state of proteins is widely studied with relevance to neurology, biochemistry, and biotechnology. In contrast with nearly amorphous aggregation, the amyloid state has a well-defined structure, consisting of parallel and antiparallel β-sheets in a periodically repeated formation. The understanding of the amyloid state is growing with the development of novel molecular imaging tools, like cryogenic electron microscopy. Sequence-based amyloid predictors were developed, mainly using artificial neural networks (ANNs) as the underlying computational technique. From a good neural-network-based predictor, it is a very difficult task to identify the attributes of the input amino acid sequence, which imply the decision of the network. Here, we present a linear Support Vector Machine (SVM)-based predictor for hexapeptides with correctness higher than 84%, i.e., it is at least as good as the best published ANN-based tools. Unlike artificial neural networks, the decisions of the linear SVMs are much easier to analyze and, from a good predictor, we can infer rich biochemical knowledge. In the Budapest Amyloid Predictor webserver the user needs to input a hexapeptide, and the server outputs a prediction for the input plus the 6 × 19 = 114 distance-1 neighbors of the input hexapeptide.

1 June 2001 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MAMahmoud Al-Khrasani
Mahmoud Al-Khrasani
GOGyörgy Orosz
György Orosz
LKLászló Kocsis
László Kocsis
VFViktor Farkas
Viktor Farkas
AMAnna Magyar
Anna Magyar
ARAndrás Z Rónai
András Z Rónai